Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
New England Journal of Medicine · 13.06.2024 · 390 (22) · 2074-2082
DOI: 10.1056/nejmoa2401530 ↗Kurz gefasst
Fallbericht in der Zeitschrift New England Journal of Medicine, erschienen am 13.06.2024. Verfasst von Metin Ozdemirli und 9 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Pathology (M.O., J.J.C.) and Gastroenterology (T.M.L.), MedStar Georgetown University Hospital, and Lombardi Comprehensive Ca…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Immunotherapy, Adoptive, Lymphoma, T-Cell, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 111-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Departments of Pathology (M.O., J.J.C.) and Gastroenterology (T.M.L.), MedStar Georgetown University Hospital, and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center (E.D., A.U.) - both…
Zitieren
APA
Ozdemirli, M., Loughney, T. M., Deniz, E., Chahine, J. J., Albitar, M., Pittaluga, S., Sadigh, S., Armand, P., Uren, A., & Anderson, K. C. (2024). Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy. New England Journal of Medicine, 390(22), 2074-2082. https://doi.org/10.1056/nejmoa2401530
Vancouver
Ozdemirli M, Loughney TM, Deniz E, Chahine JJ, Albitar M, Pittaluga S, et al. Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy. New England Journal of Medicine. 2024;390(22):2074-2082. doi:10.1056/nejmoa2401530
BibTeX
@article{Ozdemirli2024,
author = {Ozdemirli, Metin and Loughney, Thomas M and Deniz, Emre and Chahine, Joeffrey J and Albitar, Maher and Pittaluga, Stefania and Sadigh, Sam and Armand, Philippe and Uren, Aykut and Anderson, Kenneth C},
title = {Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy},
journal = {New England Journal of Medicine},
year = {2024},
volume = {390},
number = {22},
pages = {2074--2082},
doi = {10.1056/nejmoa2401530}
}
EUVIMED